Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)
Clinical trial NCT03535870 · COMPLETED
Trial details
- NCT number
- NCT03535870
- Sponsor
- West-Ward Pharmaceutical
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2019-09-10
- Enrollment
- 1556
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.